Psychopharmacology and Psychiatry Updates

265 Episodio

1. Tips for Treating Perimenopausal Depression

   Pubblicato: 28/11/2021
2. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

   Pubblicato: 23/11/2021
3. Subclinical Hypothyroidism in Depressed Adolescents

   Pubblicato: 18/11/2021
4. Principles for Managing Alcohol Use Disorder

   Pubblicato: 13/11/2021
5. ECT for Depressed Patients With Borderline Personality Disorder

   Pubblicato: 08/11/2021
6. Assessing and Treating Alcohol Withdrawal

   Pubblicato: 03/11/2021
7. Lab Tests in Psychopharmacology

   Pubblicato: 29/10/2021
8. Technology-Facilitated Adherence Enhancement and Family Involvement

   Pubblicato: 24/10/2021
9. Drug-Induced Hyperthermic Syndromes in Psychiatry

   Pubblicato: 19/10/2021
10. How to Improve Adherence: Targeting Reasons for Nonadherence

    Pubblicato: 14/10/2021
11. Esketamine: Postmarketing Safety Concerns

    Pubblicato: 09/10/2021
12. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Pubblicato: 04/10/2021
13. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Pubblicato: 29/09/2021
14. How to Assess Psychotropic Drug Adherence

    Pubblicato: 24/09/2021
15. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Pubblicato: 19/09/2021
16. Delirium, Catatonia, and COVID-19

    Pubblicato: 14/09/2021
17. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Pubblicato: 09/09/2021
18. Dopamine and Depression: Clinical Considerations

    Pubblicato: 04/09/2021
19. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Pubblicato: 30/08/2021
20. New Somatic Treatments for Child and Adolescent Depression

    Pubblicato: 25/08/2021